Precision medicine gives cancer patients hope

Dr David Tan, lead investigator of the Integrated Molecular Analysis of Cancer Programme, with Madam Tan. Being matched with a clinical trial has helped Madam Tan, who had undergone six operations to remove various organs as her ovarian cancer spread
Dr David Tan, lead investigator of the Integrated Molecular Analysis of Cancer Programme, with Madam Tan. Being matched with a clinical trial has helped Madam Tan, who had undergone six operations to remove various organs as her ovarian cancer spread.ST PHOTO: SYAMIL SAPARI

Programme helps match patients to early-phase clinical trials of new drugs

For cancer patients who have had relapses despite multiple operations, the latest precision medicine may offer them hope.

A programme by the National University Cancer Institute Singapore (NCIS) is helping to match cancer patients with certain genetic profiles to early-phase clinical trials of new drugs.

Please or to continue reading the full article. Learn more about ST PREMIUM.

Enjoy unlimited access to ST's best work

  • Exclusive stories and features on multiple devices
  • In-depth analyses and opinion pieces
  • ePaper and award-winning multimedia content
A version of this article appeared in the print edition of The Straits Times on July 16, 2018, with the headline 'Precision medicine gives cancer patients hope'. Print Edition | Subscribe